Solid oral dosage form containing an enhancer
US8883201B2 · kind B2 · utility
83Cited by
80References
31Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Jun 10, 2009 |
| Grant date | Nov 11, 2014 |
| Priority date | — |
| Expiry date | Dec 2, 2030 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P35/04
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to a pharmaceutical composition and oral dosage forms comprising a bisphosphonate in combination with an enhancer to enhance intestinal delivery of the bisphosphonate to the underlying circulation. Preferably, the enhancer is a medium chain fatty acid or a medium chain fatty acid derivative having a carbon chain length of from 6 to 20 carbon atoms, and the solid oral dosage form is a controlled release dosage form such as a delayed release dosage form.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.